Canada administers first Alzheimer's drug infusion

ctvnews.ca

Canada administered an Alzheimer's drug infusion for the first time, offering hope for extended independence. Lecanemab, approved by Health Canada, removes amyloid plaque to slow disease progression by about 30 percent. It is the last G7 nation to approve the treatment. Provincial coverage is pending, leaving families to pay the estimated $32,000 annual cost, though research is exploring its use in asymptomatic patients.


With a significance score of 5.4, this news ranks in the top 0.7% of today's 30288 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


Canada administers first Alzheimer's drug infusion | News Minimalist